Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

This study has been completed.
Information provided by:
Avant Immunotherapeutics Identifier:
First received: July 9, 2007
Last updated: June 27, 2008
Last verified: June 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)